Biocon Ltd. informed that its Active Pharmaceutical Ingredient (API) manufacturing facility in Visakhapatnam, Andhra Pradesh
Torrent Pharmaceuticals got the green light from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) to produce and sell Prucalopride Oral Solution (0.2 mg/mL).
.png "Mounjaro Becomes India's Top-Selling Drug at INR100 Crore")
Eli Lilly’s anti-obesity drug Mounjaro has become India’s highest-selling pharmaceutical by value in October, with sales touching ?100 crore ($11.38 million). The surge reflects the growing demand for anti-obesity medications in a country...
Zydus Lifesciences receives tentative USFDA approval for Olaparib Tablets (100mg, 150mg) used in treating BRCA-related ovarian, breast, pancreatic, and prostate cancers.
Alembic Pharmaceuticals Limited (Alembic), a pharmaceutical company engaged in vertically integrated research and development, has announced that it has obtained final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug
Bayer’s Kerendia™ (finerenone) approved in India for HFpEF/HFmrEF, offering dual heart-kidney protection and improving outcomes in high-risk cardiovascular patients.
Zydus Lifesciences Ltd. is set to broaden its US specialty sector with non-core molecules composition Saroglitazar. The company has a plan to use the funds from its recently approved ?5,000-crore Qualified Institutional Placement
Apollo Hospitals Enterprise Ltd. (AHEL) has demonstrated strong financial performance in the second quarter of FY26 with a 13% year-on-year (YoY) revenue increase to Rs 6,304 crore along with a 26% surge in consolidated profit
In order to guarantee that innovative tuberculosis (TB) vaccines reach adults and adolescents in high-burden nations, a new WHO report that was released on the fringes of the G20 Health Ministers Meeting in Limpopo, South Africa, argues for daring
Marksans Pharma Limited has announced that its wholly owned subsidiary in the United Kingdom, Relonchem Limited, has obtained Marketing Authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its product Exemestane 2
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")